TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 11 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | -16.7% | 6,000 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | +100.0% | 6,000 | +100.0% | 0.00% | – |
Q2 2021 | $3,000 | -25.0% | 3,000 | -25.0% | 0.00% | – |
Q1 2021 | $4,000 | -42.9% | 4,000 | -42.9% | 0.00% | – |
Q4 2020 | $7,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
Q3 2020 | $7,000 | -82.5% | 7,000 | -82.9% | 0.00% | – |
Q2 2020 | $40,000 | -64.3% | 41,000 | -66.1% | 0.00% | – |
Q1 2020 | $112,000 | +111.3% | 121,000 | +116.1% | 0.00% | – |
Q4 2019 | $53,000 | +657.1% | 56,000 | +600.0% | 0.00% | – |
Q3 2019 | $7,000 | -99.7% | 8,000 | -99.7% | 0.00% | -100.0% |
Q2 2019 | $2,411,000 | +2072.1% | 2,637,000 | +2097.5% | 0.00% | – |
Q1 2019 | $111,000 | +122.0% | 120,000 | +114.3% | 0.00% | – |
Q4 2018 | $50,000 | -94.9% | 56,000 | -94.7% | 0.00% | – |
Q3 2018 | $984,000 | +8845.5% | 1,057,000 | +8708.3% | 0.00% | – |
Q2 2018 | $11,000 | -97.6% | 12,000 | -97.7% | 0.00% | – |
Q1 2018 | $459,000 | +227.9% | 520,000 | +229.1% | 0.00% | – |
Q4 2017 | $140,000 | -70.5% | 158,000 | -70.1% | 0.00% | – |
Q3 2017 | $475,000 | +486.4% | 529,000 | +605.3% | 0.00% | – |
Q2 2017 | $81,000 | +55.8% | 75,000 | +56.2% | 0.00% | – |
Q1 2017 | $52,000 | -57.4% | 48,000 | -57.1% | 0.00% | – |
Q4 2016 | $122,000 | +662.5% | 112,000 | +761.5% | 0.00% | – |
Q3 2016 | $16,000 | +14.3% | 13,000 | +18.2% | 0.00% | – |
Q2 2016 | $14,000 | -87.5% | 11,000 | -87.2% | 0.00% | – |
Q1 2016 | $112,000 | +261.3% | 86,000 | +330.0% | 0.00% | – |
Q4 2015 | $31,000 | +40.9% | 20,000 | +25.0% | 0.00% | – |
Q3 2015 | $22,000 | +69.2% | 16,000 | +77.8% | 0.00% | – |
Q2 2015 | $13,000 | -13.3% | 9,000 | -10.0% | 0.00% | – |
Q1 2015 | $15,000 | -83.3% | 10,000 | -85.7% | 0.00% | – |
Q3 2014 | $90,000 | +2900.0% | 70,000 | +3400.0% | 0.00% | – |
Q1 2014 | $3,000 | -97.2% | 2,000 | -98.0% | 0.00% | – |
Q4 2013 | $107,000 | +245.2% | 101,000 | +236.7% | 0.00% | – |
Q2 2013 | $31,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Arena Capital Advisors, LLC- CA | 68,443,000 | $68,785,000 | 10.97% |
PIPER SANDLER & CO. | 12,550,000 | $12,425,000 | 8.95% |
Radcliffe Capital Management, L.P. | 100,783,000 | $100,279,000 | 6.28% |
INCOME RESEARCH & MANAGEMENT | 14,775,000 | $14,701,000 | 5.39% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,123,000 | 1.30% |
Bracebridge Capital, LLC | 5,500,000 | $5,390,000 | 0.82% |
Western Asset Management Company, LLC | 9,000,000 | $8,916,000 | 0.57% |
WESTWOOD HOLDINGS GROUP INC | 43,125,000 | $42,856,000 | 0.49% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,050,000 | $1,045,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,675,000 | 0.35% |